Trials / Completed
CompletedNCT01958619
Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers
Open Label Pharmacokinetic Study of OZ439 and Piperaquine Following Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in the Fasted State in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Medicines for Malaria Venture · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A healthy volunteer study to characterise the exposure of the two study medications, following administration of OZ439 + TPGS granules with piperaquine phosphate granules (intended for children) and with piperaquine phosphate tablets (intended for adults). Ideally, to confirm the exposure demonstrated in an earlier bioavailability study.
Detailed description
A Phase 1 open label parallel group, four arm study conducted in healthy male and female subject aged 18 to 55 years of age. Subjects will receive either treatment A, B, C or D as described below: * Treatment A: 1440 mg PQP tablets and 800 mg OZ439 + TPGS granules for oral suspension * Treatment B: 960 mg PQP tablets and 800 mg OZ439 + TPGS granules for oral suspension * Treatment C: 960 mg PQP granules for oral solution and 800 mg OZ439 + TPGS granules for oral suspension * Treatment D: 800 mg OZ439 + TPGS granules for oral suspension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1440mg PQP tablets | Piperaquine phosphate tablets (1440mg) |
| DRUG | 960mg PQP tablets | Piperaquine phosphate tablets (960mg) |
| DRUG | 800mg OZ439 + TPGS | OZ439 (800mg) + TPGS granules for oral suspension |
| DRUG | 960mg PQP granules | Piperaquine phosphate granules for oral solution (960mg) |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2013-10-09
- Last updated
- 2015-05-08
- Results posted
- 2015-04-21
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01958619. Inclusion in this directory is not an endorsement.